Subjects n | 60 | 59 | 78 | 98 |
Age years | 40 (31–52) | 17 (15–18) | 35 (26–45) | 14 (13–15) |
Males | 40 (67) | 55 (50) | 56 (72) | 49 (50) |
Place of birth | | | | |
Western Europe | 23 (38) | 59 (100) | 29 (37) | 38 (39) |
Africa | 19 (32) | 0 (0) | 15 (19) | 1 (1) |
South America | 2 (3) | 0 (0) | 15 (19) | 50 (51) |
Eastern Europe | 9 (15) | 0 (0) | 3 (4) | 5 (5) |
Asia | 6 (10) | 0 (0) | 11 (14) | 4 (4) |
Unknown | 1 (2) | 0 (0) | 5 (6) | 0 (0) |
BCG status | | | | |
Yes | 0 (0) | 0 (0) | 10 (13) | 59 (60) |
No | 0 (0) | 59 (100) | 28 (36) | 38 (39) |
Unknown | 60 (100) | 0 (0) | 40 (51) | 1 (1) |
Diagnosis | | | | |
Pulmonary TB | 34 (71) | 0 (0) | 72 (92) | 0 (0) |
Extrapulmonary TB | 26 (29) | 0 (0) | 6 (8) | 0 (0) |
Comorbidity | | | | |
None | 53 (87) | 59 (100) | 60 (77) | 98 (100) |
Diabetes mellitus | 0 (0) | 0 (0) | 5 (6) | 0 (0) |
HCV | 0 (0) | 0 (0) | 5 (6) | 0 (0) |
HIV | 7 (13) | 0 (0) | 3 (4) | 0 (0) |
HIV+HCV | 0 (0) | 0 (0) | 2 (3) | 0 (0) |
HIV+HBV | 0 (0) | 0 (0) | 1 (1) | 0 (0) |
Renal transplant + steroids | 0 (0) | 0 (0) | 1 (1) | 0 (0) |
Tests | | | | |
TST positive/tested | 0/0 (0) | 0/53 (0) | 16/28 (57) | 18/96 (19) |
TST mm | 0.0 (0–0) | 0.0 (0–0) | 15 (10–18) | 9 (6–12) |
TST not performed /unavailable | 60 (100) | 6 (10) | 50 (64) | 2 (2) |
Culture or NAAT +ve/tested | 60/60 (100) | NA | 78/78 (100) | NA |
Microscopy +ve/-ve/NA | 29 (48)/25 (42)/6 (10) | NA | 59 (76)/18 (23)/1 (1) | NA |